Literature DB >> 14503021

Comparison between Alzheimer's disease and vascular dementia: implications for treatment.

Raj N Kalaria1.   

Abstract

Virtually 90% of the elderly with late-onset dementia exhibit neuropathological features consistent with Alzheimer's disease (AD), vascular dementia (VaD) or dementia with Lewy bodies (DLB), alone or in combination. Both AD and DLB reveal extensive senile plaques containing amyloid beta whereas neurofibrillary tangles evident as tau pathology are fewer in DLB, which also bears diffuse cortical Lewy bodies. Interestingly, however, there is considerable overlap between AD and VaD in terms of both risk factors and pathology. Cholinergic deficits are also encountered in VaD, which like AD may respond to cholinergic therapy. Cerebrovascular pathology, ischemic brain damage and autonomic dysregulation resulting in cerebral hypoperfusion appears fundamental in the pathogenesis of late-onset dementias.

Entities:  

Mesh:

Year:  2003        PMID: 14503021     DOI: 10.1179/016164103101201968

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  14 in total

1.  Early biomarkers for post-stroke cognitive impairment.

Authors:  Lai Qian; Lidong Ding; Liqun Cheng; Xiaolei Zhu; Hui Zhao; Jiali Jin; Dening Guan; Bing Zhang; Xuemei Chen; Yun Xu
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

Review 2.  Is apolipoprotein E4 an important risk factor for vascular dementia?

Authors:  Troy T Rohn
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Analysis of viral and genetic factors in South African patients with multiple sclerosis.

Authors:  J Nico P de Villiers; Florette K Treurnicht; Louise Warnich; Jonathan Carr; Susan J van Rensburg; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2006-07-22       Impact factor: 3.584

4.  Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.

Authors:  Pedro Gil; José Luis Dobato Ayuso; José Manuel Marey; Manuel Antón; Carlos Guzmán Quilo
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 5.  Vascular dementia: pharmacological treatment approaches and perspectives.

Authors:  Andrius Baskys; Anthony C Hou
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

6.  Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.

Authors:  N Thavichachart; K Phanthumchinda; S Chankrachang; R Praditsuwan; S Nidhinandana; V Senanarong; N Poungvarin
Journal:  Int J Clin Pract       Date:  2006-05       Impact factor: 2.503

7.  Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain.

Authors:  Ryan J Day; Maria J Mason; Chloe Thomas; Wayne W Poon; Troy T Rohn
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

8.  Cardioprotection and anticholinesterases in patients with Alzheimer's disease: time for reappraisal.

Authors:  Fiammetta Monacelli; Patrizio Odetti; Marina Sartini; Antonello Parodi; Claudio Brunelli; Gianmarco Rosa
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-02-14

9.  Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy.

Authors:  Joseph O Ojo; Jon M Reed; Gogce Crynen; Prashanthi Vallabhaneni; James Evans; Benjamin Shackleton; Maximillian Eisenbaum; Charis Ringland; Anastasia Edsell; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Front Aging Neurosci       Date:  2021-05-17       Impact factor: 5.750

Review 10.  Role of apolipoprotein E in neurodegenerative diseases.

Authors:  Vo Van Giau; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.